Alerts will be sent to your verified email
Verify Email
MAKERSL
|
Makers Laboratories
|
Bharat Immunological
|
Biofil Chem & Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
0.31 % | -29.83 % | 4.39 % |
|
5yr average Equity Multiplier
|
2.36 | 3.08 | 2.06 |
|
5yr Average Asset Turnover Ratio
|
0.7 | 0.61 | 0.95 |
|
5yr Avg Net Profit Margin
|
-0.21 % | -18.38 % | 2.38 % |
|
Price to Book
|
1.16 | 1.13 | 3.41 |
|
P/E
|
0.0 | 0.0 | 22.89 |
|
5yr Avg Cash Conversion Cycle
|
75.08 Days | 206.63 Days | 75.63 Days |
|
Inventory Days
|
107.1 Days | 125.06 Days | 28.27 Days |
|
Days Receivable
|
71.83 Days | 61.4 Days | 389.8 Days |
|
Days Payable
|
106.28 Days | 117.81 Days | 203.89 Days |
|
5yr Average Interest Coverage Ratio
|
4.73 | -2.32 | 23.53 |
|
5yr Avg ROCE
|
6.35 % | -44.64 % | 6.37 % |
|
5yr Avg Operating Profit Margin
|
7.59 % | -18.7 % | 3.78 % |
|
5 yr average Debt to Equity
|
0.21 | 0.71 | 0.03 |
|
5yr CAGR Net Profit
|
n/a | 23.51 % | -14.7 % |
|
5yr Average Return on Assets
|
0.25 % | -10.1 % | 2.37 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
61.27 % | 59.25 % | 46.79 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | -0.03 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Makers Laboratories
|
Bharat Immunological
|
Biofil Chem & Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Segment Break-Up
|
Segment Break-Up
|
-
|
-
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|
-
|
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
-
|
Operating Profit Break-Up
|
|
Asset Break-Up
|
Asset Break-Up
|
Asset Break-Up
|
-
|